Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chantix's Boxed Warning: Will A Positive Vote Justify A Negative Outcome?

Dec 07 2016

• By Derrick Gingery

smoking cigarette in the hand of young man close up

Related Content

REMS Communications Need FDA Logo To Boost Doctors’ Attention, Advisors Say

Dec 23 2013

Gilead's Letairis Gets Boost Against Actelion's Tracleer With Removal Of Liver Warning

Mar 04 2011

US FDA orders "black box" suicidality warnings and studies for Chantix and Zyban

Jul 02 2009

Was FDA Nit-Picking In Criticism Of Pfizer's EAGLES Trial?

Dec 07 2016

Pfizer's Pitch For Chantix Warning Reduction Focuses On Those With Mental Illness

Dec 07 2016

Removing Pfizer's Chantix Boxed Warning A One-Off, Committee Says

Sep 15 2016

Pfizer's Chantix Warning May Remain As FDA Raises Trial Concerns

Sep 12 2016

Related Companies

Pfizer Inc.

GSK plc

Gilead Sciences, Inc.

Additional Topics

United States Advisory Committees Clinical Trials Safety Drug Review Regulation Risk Management BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window